Matsubayashi H - Search Results

1

Aberrant methylation of Reprimo correlates with genetic instability and predicts poor prognosis in pancreatic ductal adenocarcinoma.

Sato N, Fukushima N, Matsubayashi H, Iacobuzio-Donahue CA, Yeo CJ, Goggins M. Sato N, et al. Among authors: matsubayashi h. Cancer. 2006 Jul 15;107(2):251-7. doi: 10.1002/cncr.21977. Cancer. 2006. PMID: 16752411 Free article.

2

Diagnosing pancreatic cancer using methylation specific PCR analysis of pancreatic juice.

Fukushima N, Walter KM, Uek T, Sato N, Matsubayashi H, Cameron JL, Hruban RH, Canto M, Yeo CJ, Goggins M. Fukushima N, et al. Among authors: matsubayashi h. Cancer Biol Ther. 2003 Jan-Feb;2(1):78-83. doi: 10.4161/cbt.183. Cancer Biol Ther. 2003. PMID: 12673124 Free article.

3

Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues.

Matsubayashi H, Sato N, Fukushima N, Yeo CJ, Walter KM, Brune K, Sahin F, Hruban RH, Goggins M. Matsubayashi H, et al. Clin Cancer Res. 2003 Apr;9(4):1446-52. Clin Cancer Res. 2003. PMID: 12684418

4

Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays.

Sato N, Fukushima N, Maitra A, Matsubayashi H, Yeo CJ, Cameron JL, Hruban RH, Goggins M. Sato N, et al. Among authors: matsubayashi h. Cancer Res. 2003 Jul 1;63(13):3735-42. Cancer Res. 2003. PMID: 12839967

5

Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma.

Sato N, Maitra A, Fukushima N, van Heek NT, Matsubayashi H, Iacobuzio-Donahue CA, Rosty C, Goggins M. Sato N, et al. Among authors: matsubayashi h. Cancer Res. 2003 Jul 15;63(14):4158-66. Cancer Res. 2003. PMID: 12874021

6

SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions.

Sato N, Fukushima N, Maehara N, Matsubayashi H, Koopmann J, Su GH, Hruban RH, Goggins M. Sato N, et al. Among authors: matsubayashi h. Oncogene. 2003 Aug 7;22(32):5021-30. doi: 10.1038/sj.onc.1206807. Oncogene. 2003. PMID: 12902985

7

Polymorphisms of SPINK1 N34S and CFTR in patients with sporadic and familial pancreatic cancer.

Matsubayashi H, Fukushima N, Sato N, Brune K, Canto M, Yeo CJ, Hruban RH, Kern SE, Goggins M. Matsubayashi H, et al. Cancer Biol Ther. 2003 Nov-Dec;2(6):652-5. Cancer Biol Ther. 2003. PMID: 14688470

8

Identification of maspin and S100P as novel hypomethylation targets in pancreatic cancer using global gene expression profiling.

Sato N, Fukushima N, Matsubayashi H, Goggins M. Sato N, et al. Among authors: matsubayashi h. Oncogene. 2004 Feb 26;23(8):1531-8. doi: 10.1038/sj.onc.1207269. Oncogene. 2004. PMID: 14716296

9

A small cell carcinoma of the pancreas with a high level of serum ProGRP.

Matsubayashi H, Fujiwara S, Kobayashi Y, Iiri T, Mitra A, Goggins M, Hruban RH, Moriyasu F. Matsubayashi H, et al. J Clin Gastroenterol. 2004 Oct;38(9):834-5. doi: 10.1097/01.mcg.0000140189.65405.2d. J Clin Gastroenterol. 2004. PMID: 15365423 No abstract available.

10

The chemokine receptor CXCR4 is regulated by DNA methylation in pancreatic cancer.

Sato N, Matsubayashi H, Fukushima N, Goggins M. Sato N, et al. Among authors: matsubayashi h. Cancer Biol Ther. 2005 Jan;4(1):70-6. doi: 10.4161/cbt.4.1.1378. Epub 2005 Jan 15. Cancer Biol Ther. 2005. PMID: 15662133 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

450 results

Search Page

Filters